other

Updated:

UroPartners

UroPartners is a urology-focused physician group and investment platform in North America, operating as an MSO to consolidate independent urology...

UroPartners

UroPartners consolidates urology practices across the United States, forming one of the largest urology groups by physician count. The entity structures its operations as a management services organization (MSO) that provides back-office support, revenue cycle management, and strategic resources for partner physicians. It does not disclose a founding year nor named principals in public records. The firm's investment strategy focuses on acquiring established urology practices and integrating them into a unified care network. It targets reimbursement optimization, clinical trial access, and equipment cost reduction through scale. Known portfolio includes acquired practices in several states, but specific names are not publicly listed. The geographic footprint covers North America only, with no confirmed offices abroad. UroPartners does not publicly disclose its AUM, number of professionals, or deployment figures. There are no known philanthropic foundations or adjacent vehicles. The firm appears to operate as a single entity rather than a family office or asset manager. The structural differentiator for UroPartners is its specialty-specific MSO model. By focusing solely on urology, it avoids the diversification challenges of multi-specialty platforms. This allows deeper expertise in urology-specific billing codes, regulatory compliance, and clinical research partnerships. Succession and governance structures are not publicly detailed.

Website
null

General information

Firm type

null

Year founded

AUM

Undisclosed

Location

Region

North America

Country

null

City

null

Corporate office

null

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at UroPartners?

UroPartners does not publicly disclose its investment leadership. The management team likely includes healthcare executives and physicians, but names are not available from public sources.

How does UroPartners source proprietary deal flow?

The firm likely sources deals through direct relationships with independent urology practices seeking consolidation. As a specialty-focused entity, it may also attract referrals from practice valuations or industry conferences.

What investment stages does UroPartners typically target?

UroPartners appears focused on acquiring mature, independent urology practices rather than early-stage startups. This is consistent with a roll-up strategy in established healthcare services.

Does UroPartners participate in fund commitments or only direct deals?

Public records suggest UroPartners operates through direct acquisitions of physician practices. There is no evidence of fund commitments to external managers.

Which sectors does UroPartners explicitly avoid?

By stated focus on urology, the firm avoids general healthcare services outside its specialty. No formal avoidance list is published.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo